Document is current
Any future updates will be listed below
-
Authors
Hatakeyama, Shingo https://orcid.org/0000-0002-0026-4079
Fujita, Naoki
Kobayashi, Mizuki
Kandori, Shuya
Ikarashi, Daiki
Fukuhara, Hiroki
Sato, Takuma
Myoen, Shingo
Uemura, Motohide
Inoue, Takamitsu
Oikawa, Masaaki
Kaiho, Yasuhiro
Miyazaki, Jun
Kojima, Yoshiyuki
Adachi, Hisanobu
Ito, Akihiro
Tsuchiya, Norihiko
Obara, Wataru
Nishiyama, Hiroyuki
Habuchi, Tomonori
Ohyama, Chikara
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (20K09517)
- License Information
-
More Information
Article History
Received: 10 March 2025
Accepted: 9 July 2025
First Online: 12 July 2025
Declarations
:
: Shingo Hatakeyama received honoraria from Janssen Pharmaceutical K.K., Astellas Pharma Inc., AstraZeneca K.K., Ono Pharmaceutical Co., Ltd., Bayer AG, Pfizer Inc., Bristol-Myers Squibb, Merck Biopharma Co., Ltd., Kaneka Corporation, and Nipro Corporation. Hiroyuki Nishiyama received honoraria from Astellas, BMS, Janssen, MSD, Ono, and Pfizer, and a grant from Chugai and Astellas. The other authors have no conflicts of interest to declare. Tomonori Habuchi received honoraria from Janssen Pharmaceutical K.K., Nippon Kayaku Co., LTD., Takeda Pharmaceutical Company Ltd., Astellas Pharma Inc., Daiichi Sankyo Company, Ltd., AstraZeneca K.K., Sanofi S.A., Novartis Pharmaceuticals and Bayer AG. Tomonori Habuchi also received research funding supports from Mochida Pharmaceutical Co., Novartis Pharmaceuticals Co, LTD., Pharmaceuticals Co, LTD. and Sysmex Co. Wataru Obara received honoraria from Astellas Pharma Inc., AstraZeneca K.K., Ono Pharmaceutical Co., Ltd., Bristol-Myers Squibb, Merck Biopharma Co., Ltd., Takeda Pharmaceutical Company Ltd., Merck Biopharma. Norihiko Tsuchiya received honoraria from Janssen Pharmaceutical K.K., Pfizer Inc., Takeda Pharmaceutical Co. Ltd., Astellas Pharma Inc., Ono Pharmaceuticals Co., Ltd., MSD K.K., Merk & Co., Inc. Other authors have no conflicts of interest to declare.
: The need for informed consent to participate was waived by an Institutional Review Board by the ethics committee of the Hirosaki University School of Medicine and all participating hospitals. Written informed consent was not obtained from individual patients due to the use of an opt-out approach.
: All authors approved for the publication.
